Carfilzomib Plus Belinostat in Relapsed/Refractory NHL
Clinical trial NCT02142530 · COMPLETED
Trial details
- NCT number
- NCT02142530
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-03-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.